InvestorsHub Logo
Followers 0
Posts 2
Boards Moderated 0
Alias Born 05/27/2015

Re: lamst post# 578

Sunday, 06/14/2015 2:58:13 PM

Sunday, June 14, 2015 2:58:13 PM

Post# of 8339
Back to $14-15 where it should have been before the P2b announced in September 2014. The company has only made advancements (P3 for FB, P2 on PTSD and tension headache) since then, especially with the FDA's agreement on the 30% pain responder as their P3 primary endpoint for FB. Should be back to $14 or higher soon.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TNXP News